Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Shareholder's Equity

v3.21.1
Condensed Consolidated Statement of Shareholder's Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated deficit
Total
Balance as of beginning of period at Dec. 31, 2019 $ 11 $ 202,796 $ (258,675) $ (55,868)
Balance as of beginning of period (shares) at Dec. 31, 2019 108,838,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of shares upon exercise of stock options (shares) 424,000      
Gain on extinguishment of related party convertible debt   8,264   8,264
Stock-based compensation   389   389
Net loss and comprehensive loss     (30,890) (30,890)
Balance as of end of period at Mar. 31, 2020 $ 11 211,449 (289,565) (78,105)
Balance as of end of period (shares) at Mar. 31, 2020 109,262,000      
Balance as of beginning of period at Dec. 31, 2020 $ 24 910,579 (345,361) 565,242
Balance as of beginning of period (shares) at Dec. 31, 2020 235,753,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Proceeds from exercise of public warrants   6,867   $ 6,867
Proceeds from exercise of public warrants (shares) 597,000     597,114
Repurchase of unvested shares - forfeitures   (2)   $ (2)
Repurchase of unvested shares - forfeitures (shares) (118,000)      
Issuance of shares for restricted stock units vested (shares) 1,230,000      
Issuance of shares upon exercise of stock options (shares) 37,000      
Stock-based compensation   45,146   45,146
Conversion of private placement warrants to public warrants   8,252   8,252
Net loss and comprehensive loss     (15,227) (15,227)
Balance as of end of period at Mar. 31, 2021 $ 24 $ 970,842 $ (360,588) $ 610,278
Balance as of end of period (shares) at Mar. 31, 2021 237,499,000